Related Experiment Video
Updated: Sep 21, 2025

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
Published on: November 27, 2019
Sex-specific differences in metabolic outcomes after sleeve gastrectomy and intermittent fasting in obese middle-aged
Ana B Emiliano1, Natalie R Lopatinsky1, Marko Kraljević1,2
1Columbia University Medical Center, New York, New York.
Abstract:
Despite the high prevalence of obesity among middle-aged subjects, it is unclear if sex differences in middle age affect the metabolic outcomes of obesity therapies. Accordingly, in this study, middle-aged obese female and male mice were randomized to one of three groups: sleeve gastrectomy (SG), sham surgery ad libitum (SH-AL), or sham surgery with weight matching to SG through intermittent fasting with calorie restriction (SH-IF). Comprehensive measures of energy and glucose homeostasis, including energy intake, body weight, energy expenditure, glucose and insulin tolerance, and interscapular brown adipose tissue (iBAT) sympathetic innervation density were obtained. At the end of 8 wk, SG and SH-IF females had better metabolic outcomes than their male counterparts. SG females had improved weight loss maintenance, preservation of fat-free mass (FFM), higher total energy expenditure (TEE), normal locomotor activity, and reduced plasma insulin and white adipose tissue (WAT) inflammatory markers. SH-IF females also had lower plasma insulin and WAT inflammatory markers, and higher TEE than SH-IF males, despite their lower FFM. In addition, SH-IF females had higher iBAT sympathetic nerve density than SG and SH-AL females, whereas there were no differences among males. Notably, SH-IF mice of both sexes had the most improved glucose tolerance, highlighting the benefits of fasting, irrespective of weight loss. Results from this study demonstrate that in middle-aged obese mice, female sex is associated with better metabolic outcomes after SG or IF with calorie restriction. Clinical studies are needed to determine if sex differences should guide the choice of obesity therapies.NEW & NOTEWORTHY SG or IF with calorie restriction produces better metabolic outcomes in females than in males. IF with calorie restriction prevents metabolic adaptation, even in the face of fat-free mass loss. IF with calorie restriction in females only, is associated with increased iBAT sympathetic innervation, which possibly mitigates reductions in energy expenditure secondary to fat-free mass loss. Lastly, IF leads to better glucose homeostasis than SG, irrespective of sex.
Insights
Middle-aged obese females show better metabolic outcomes than males after weight loss surgery or intermittent fasting. Intermittent fasting improves glucose tolerance in both sexes, regardless of weight loss.
Area of Science:
- Metabolic research
- Obesity therapeutics
- Sex differences in physiology
Background:
- Obesity is highly prevalent in middle-aged individuals.
- The impact of sex differences on obesity treatment outcomes in middle age is not well understood.
- Current obesity therapies may have variable efficacy based on sex.
Purpose of the Study:
- To investigate sex differences in metabolic outcomes following obesity therapies in middle-aged mice.
- To compare the effects of sleeve gastrectomy (SG) and intermittent fasting with calorie restriction (SH-IF) versus sham surgery (SH-AL).
- To assess energy and glucose homeostasis parameters in response to different interventions.
Main Methods:
- Middle-aged obese male and female mice were randomized into three groups: SG, SH-AL, or SH-IF.
- Metabolic assessments included energy intake, body weight, energy expenditure, glucose and insulin tolerance tests.
- Interscapular brown adipose tissue (iBAT) sympathetic innervation density was quantified.
Main Results:
- Both SG and SH-IF female mice exhibited superior metabolic outcomes compared to males.
- Females showed better weight loss maintenance, preserved fat-free mass (FFM), higher total energy expenditure (TEE), and reduced inflammatory markers.
- Intermittent fasting improved glucose tolerance in both sexes, and females demonstrated increased iBAT sympathetic nerve density.
Conclusions:
- Female sex is associated with enhanced metabolic benefits from sleeve gastrectomy or intermittent fasting in middle-aged obese mice.
- Intermittent fasting effectively improves glucose homeostasis and prevents metabolic adaptation, even with FFM loss.
- Further clinical studies are warranted to determine if sex should guide obesity therapy selection.

